Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-12-06Clinical Trial Update: CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 trial evaluating CAR-pNK cell immunotherapy for MUC1-positive relapsed or refractory solid tumors; current status is not provide…
-
CLINICAL_TRIALS research · 2016-12-06Clinical Trial Update: Laparoscopic Versus Open Gastrectomy With Splenic Hilum Lymph Nodes Dissection [Phase 3]
This entry summarizes an ongoing Phase 3 clinical trial comparing laparoscopic versus open gastrectomy with splenic hilum lymph node dissect…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 CAR-T cell therapy targeting MUC1 is being investigated for glioblastoma, colorectal cancer, and gastric cancer.
-
CLINICAL_TRIALS research · 2016-11-29Clinical Trial Update: Mucolytic Solution Before Upper Endoscopy [NA]
Clinical trial update about using a mucolytic solution before upper endoscopy. Gastric cancer is listed as an associated condition.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer [Phase 3]
A Phase 3 trial of Herceptin with cisplatin and capecitabine in HER2-positive metastatic gastric or gastroesophageal junction cancer was ter…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach [Phase 1, Phase 2]
Phase I/II trial evaluating tivantinib with FOLFOX for advanced solid tumors including metastatic adenocarcinoma of the distal esophagus, ga…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer [NA]
Clinical trial comparing laparoscopic bursectomy with D2 lymphadenectomy to laparoscopic D2 lymphadenectomy alone in advanced gastric cancer…
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis [Phase 2]
Phase 2 study evaluating neoadjuvant peritoneal and systemic chemotherapy plus HIPEC in gastric carcinomatosis is currently suspended. Spons…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer [Phase 2]
This document reports a Phase 2 clinical trial assessing the efficacy and safety of Everolimus (RAD001) in patients with advanced gastric ca…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer [Phase 2]
Phase 2 trial update of first-line trastuzumab plus docetaxel and capecitabine in HER2-positive advanced gastric cancer.
-
CLINICAL_TRIALS research · 2016-11-10Clinical Trial Update: Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
This clinical trial update describes a Korean study investigating antibiotic susceptibility testing for Helicobacter pylori. The conditions …
-
CLINICAL_TRIALS research · 2016-11-09Clinical Trial Update: Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer [Phase 3]
Phase 3 trial update on perioperative chemotherapy combined with HIPEC for high-risk advanced gastric cancer; current status of the trial is…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer. [Phase 2]
A Phase 2 clinical trial evaluating Xeloda (capecitabine) as first-line chemotherapy for advanced or metastatic gastric cancer has completed…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer [Phase 3]
This entry reports the completion of a Phase 3 clinical trial evaluating capecitabine (Xeloda) in patients with advanced or metastatic gastr…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer [Phase 3]
Phase 3 trial evaluating Onartuzumab in combination with mFOLFOX6 for metastatic HER2-negative, MET-positive gastric/gastroesophageal cancer…
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric Cancer
This document reports a completed non-interventional study evaluating Xeloda (capecitabine) in patients with gastric cancer.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics
This is a completed non-interventional study sponsored by Hoffmann-La Roche that assesses the occurrence rates of several cancers in Turkey …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer [Phase 3]
Phase 3 clinical trial evaluating capecitabine-containing combination chemotherapy versus surgery alone in gastric cancer has completed.
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer
This entry notes the completion of a clinical trial investigating physical and psychosocial rehabilitation needs in patients after diagnosis…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial tested the combination of docetaxel, 5-fluorouracil, and oxaliplatin in patients with gastric cancer or gastroeso…
-
CLINICAL_TRIALS research · 2016-10-31Clinical Trial Update: Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant SEEOX chemotherapy for Borrmann Type 4 gastric cancer; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma
Roche-sponsored clinical trial update on HER-2 status in gastric and gastroesophageal junction cancers; the study is completed and results w…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Postoperative Analgesic Effect of Nefopam [NA]
A completed clinical trial evaluated the postoperative analgesic effect of nefopam in patients with gastric cancer.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors [NA]
A clinical trial from University Hospital Tuebingen compares short-term starvation versus a normal diet before chemotherapy in solid tumors;…
-
CLINICAL_TRIALS research · 2016-10-28Clinical Trial Update: Iron Replacement in Oesophagogastric Neoplasia [Phase 4]
This document provides an update on a Phase 4 trial of iron replacement therapy for anemia in patients with esophageal or gastric cancer.